Blog
The surge in RWE supported FDA approvals: A look at three FDA decisions
The U.S. Food and Drug Administration (FDA) is approving more drugs with the help of ...
Blog
Optimizing pharma organizational design for effective use of real-world evidence
Across the pharma product lifecycle, factors like the regulatory environment and business ...
Blog
How RWE can inform cancer care: Q&A with Dr. Deb Schrag, oncologist and observational researcher
Real-world evidence (RWE) has emerged as a useful tool for industry and regulators in ...
Blog
How can you leverage RWE to help advance your organization’s goals? Q&A with Dr. Yin Ho
Trained as an emergency medicine physician, Yin Ho, M.D., M.B.A., stepped out of the ...
Blog
How to plan for evidence generation in a time of uncertainty
Much of my time lately has been dedicated to contemplating the magnitude of COVID-19’s ...
Blog
COVID-19: Recommended readings and resources from Aetion scientists
Over the past few weeks, we’ve been adjusting to the many changes and uncertainties ...
Blog
Making the business case for RWE: Julie Schiffman’s advice for biopharma on leveraging data to drive impact
How can teams within biopharma ensure their real-world evidence (RWE) studies make the ...
Blog
Psychiatrist and health care CEO Dr. Gary Gottlieb: Treating the patient as a whole person
With his previous professional experience ranging from CEO of Massachusetts-based ...
Blog
Aetion, Dr. Scott Gottlieb, biopharma leaders’ discussions at JPM 2020: It’s time to “knock on an open door” to further RWE standards and acceptance
This January, in the whirlwind week of the 36th Annual J.P. Morgan Healthcare Conference ...
Blog
How to amplify RWE clarity and reproducibility with data visualizations: Q&A with Dr. Shirley Wang of the REPEAT initiative
While analyses of non-randomized health care databases—insurance claims, electronic ...
Blog
Artificial Intelligence in Health Care - GAO Report
Benefits and Challenges of Machine Learning in Drug Development The adoption of ...
Blog
Why diverse data teams lead to bigger wins, and other perspectives from retail tech: A Q&A with Stitch Fix CTO, Cathy Polinsky
Cathy Polinsky’s deep love of programming, problem-solving, and perfecting client ...
Blog
How emerging technologies will ensure increasing availability of RWD
The potential of real-world data (RWD) to transform clinical trials is drawing attention ...
Blog
Contextual considerations in RWE generation and use
There’s a lot of buzz around the potential impact of real-world evidence (RWE) in health ...
Blog
The shift from health technology assessment to management: What is RWE’s role?
As innovation in health care advances—and the associated costs escalate—payers are ...
Blog
RWE use by HTAs: How has it evolved, and where is it headed next? Q&A with Dr. Jens Grueger
Health technology assessment (HTA) agencies are increasingly turning to real-world ...
Blog
RWE and the value equation: U.S. health care purchaser perspectives on payment model evolution and the role of RWE
Much discussion surrounds rising drug prices—and the numerous parties affected. ...
Blog
Let’s talk about value: How biopharma can maximize utility of RWE in value discussions
With the drug pricing pressures mounting on a global scale, there is a clear and imminent ...
Blog
Ask our experts: Working with real world data sets: What types of questions can your data answer?
The promise of real-world evidence (RWE) comes with a steep learning curve. As regulators ...
Blog
Managing the Risks from AI Algorithms
In the webinar organized by Replica Analytics in November 2019 entitled "Managing the ...
Blog
Advancing cancer care with real-world data: Next steps for collaborators
In oncology, over 90 percent of patient treatment experiences occur outside of clinical ...
Blog
Evidence at the Apex: Five learnings from the first annual Aetion Summit
Last month, the inaugural Aetion Summit in New York City brought together some of the ...
Blog
Learnings from three FDA decisions on ECA submissions in oncology
The publication of the Framework for FDA’s Real-World Evidence Program nearly a year ago ...
Blog
Spotlight on trust and transparency at ISPOR Europe 2019
The digital age has transformed the amount and quality of data available and given rise ...